Abstract
Cochlear implants (CIs) restore hearing in patients with severe to profound deafness by delivering electrical stimuli inside the cochlea. The high electrical conductivity inside the cochlea, however, causes the electrical stimulus to spread, reducing speech comprehension. Understanding the stimulus spread in an individual patient is hampered by the poor accessibility of the inner ear and by the lack of suitable in vitro or in vivo models. Here, we report on the development of a neural network model that is informed by measurements in 3D printed biomimetic cochleae with realistic conductivity and anatomy. Using four geometric features captured in patients’ pre-operative CT scans, the model can reconstruct patients’ clinical electric field imaging (EFI) profiles arising from off-stimulation positions with a 90% mean accuracy (n=6). Moreover, the model informs the stereotypical cochlear geometries prone to stimulus spread and replicates the uncommon clinical occurrence of the ‘mid-dip’ EFI profiles. This work enables on-demand printing of patient-relevant cochlear models for CI testing, and directly reveals individual patient’s in vivo cochlear tissue resistivity (0.6 – 15.9kΩcm, n=16) by CI telemetry.
Competing Interest Statement
M.B. received research funding from Advanced Bionics®, Cochlear Corporation®, and in-kind contribution from MED-EL® on other research areas but not on the present study. The remaining authors declare no competing interests.
Funding Statement
This work was supported by the European Research Council (ERC-StG, 758865), the Cambridge Hearing Trust and the Evelyn Trust. We thank Advanced Bionics Corporation® for providing cochlear implants and software on this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The use of anonymous patient EFI profiles and CT scans in our study was approved by the Cambridge Biomedical Research Centre (Ref: A095451).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵# Lead contact: yysh2{at}cam.ac.uk
Data Availability
The raw data generated in the study are available for research purposes from the corresponding author upon appropriate request.
